Second Annual AI & Drug Discovery Symposium: Revolutionizing the Future of Medicine

Goodwin is hosting our Second Annual AI & Drug Discovery Symposium at our Boston office on October 1. This event will bring together leaders across life sciences, technology, and investment to discuss the opportunities and challenges shaping the next generation of AI-enabled drug discovery. Through engaging conversations and expert insights, we'll explore emerging market and investment dynamics, innovative collaboration models, regulatory and policy considerations, and approaches to creating, protecting, and maximizing value across proprietary data, intellectual property, and AI-enabled platforms in an evolving life sciences landscape. Discussion topics will include: Market and Investment Trends in AI and Life Sciences Redefining Collaboration: New Partnership Models in Drug Discovery Regulatory & Policy Perspectives Intellectual Property Strategy in the Age of AI AI Governance and Security The program will conclude with a networking reception, offering attendees the opportunity to connect with fellow executives, investors, advisors, and innovators across the life sciences and technology ecosystems over drinks and light refreshments.